The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001247369
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
18/09/2026
Date registered
Help: Date registered
14/10/2026
Date last updated
Help: Date last updated
14/10/2026
Date data sharing statement initially provided
Help: Data sharing statement date
14/10/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Feasibility, acceptability and appropriateness of a specialist sleep assessment and treatment centre model of care to support sleep disorder management in shift workers
Scientific title
Feasibility, Acceptability and Appropriateness of a Specialist Sleep Assessment and Treatment Centre for early career shift workers: The ACCESS for Shift Work Trial
Additional trial identifiers [1] 318466 0
Nil
Universal Trial Number (UTN)
Trial acronym
The ACCESS for Shift Work Trial
Related trial records

Health condition
Health condition(s) studied:
Disrupted circadian rhythms 343638 0
Insomnia Disorder 343639 0
Obstructive sleep apnoea 343640 0
Comorbid sleep disorders 343641 0
Circadian rhythm sleep-wake disorders 343642 0
Delayed Sleep-Wake Phase Disorder 343643 0
Condition category
Condition code
Public Health 339752 339752 0 0
Other public health

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Intervention: This pilot implementation trial is designed to assess the feasibility, acceptability and appropriateness of accessing a model of sleep disorder assessment, diagnosis and treatment which is tailored to the needs of shift workers and designed by the research team. The intervention is a centralised assessment and diagnosis protocol spanning 4-5 weeks of hybrid assessment (online, telephone and in-person monitoring and assessment), and provision of a tailored diagnostic report for the participant to keep at a diagnostic appointment (T0). Per delivery, the stakeholders involved in assessment, diagnosis and treatment are Ahpra registered psychologists and physicians. The diagnosis and assessment phase comprises the first 4-5 weeks of the trial. (weeks -1 to -5) Participants are offered first-line, evidence-based treatment pathways which can have variable timelines (ie tailored to the individual sleep disorder presentations). Follow up is for 6 months following diagnosis.

Delivery: The trial will be delivered by Ahpra registered psychologists and physicians with training in behavioural sleep medicine and expertise working with shift workers. The trial is supported by research assistants with training in epidemiology, occupational therapy and/or psychology with a sleep focus.

Mode of delivery: The trial will be delivered with a hybrid methodology to reduce face to face burden on participants, facilitate participation outside of 9-5 clinical hours for those on non-standard schedules, and support engagement. Stages of the trial include:
-electronic and telephone screening (weeks 1-2, one call, and one electronic survey)
-face to face appointment (week 2) to set up overnight polysomnography equipment (one night) with trained laboratory technicians and research assistants, and commence remote monitoring using wearable and/or nearable devices (weeks 3-4). Participants will be provided with details about fitting / using devices, including the nearable Withings Sleep Analyser (under the mattress), sleep wearable Somfit (7-10 days, self applied) , and light pin wearable miEye (up to 14 days). Remote monitoring will be prior to diagnosis (ie weeks -5 to T0); with the exception of Withings which can be maintained under the mattress until trial conclusion.
Clinical interview (end week 2) will be conducted either face to face (ideal) or using telehealth for participants who may be based remotely. This interview will be conducted by a sleep psychologist, alongside a non-invasive pupil assessment by a trained research assistant.

Duration of delivery: The trial will comprise a baseline data collection window for electronic data capture of 4-5 weeks, subject to participant schedules and availability. Assessment and diagnostic information will be provided from the Shift Work Clinic @ AISH Sleep Health Clinics (Flinders University, formerly the Adelaide Institute for Sleep Health).

For participants who choose to engage with treatment which is offered (ie, best practice treatment for their presenting sleep disorder), session delivery duration will vary by presenting sleep disorder but may include multiple sessions (up to 10) of cognitive behavioural therapy for insomnia (CBTi) for presenting behavioural sleep medicine conditions, and up to 5 follow-up sessions for obstructive sleep apnoea (OSA) or hypersomnolence management with a qualified sleep physician for indicated sleep disorders.

CBTi Sessions will be tailored to patient needs with regards to frequency and timing, but broadly will comprise ~45 minute sessions, covering cognitive or behavioural interventions in accordance with clinical practice guidelines for insomnia management. Sleep Psychologists will oversee delivery.

OSA/hypersomnolence session count and timing will be at the discretion of the treating physician at the AISH Sleep Health Clinics. Sessions are typically 30-60 minutes subject to complexity, and according to patient needs and preferences for appointment scheduling. The trial accounts for up to 5 sessions with a sleep physician. These sessions will cover evidence-based treatment (e.g. introduction of continuous positive airway pressure (CPAP), mandibular advancement splints (MAS), or relevant pharmacological treatment in accordance with clinical practice guidelines, will be delivered by a sleep physician, and will be subject to determination of a diagnosis by the treating sleep physician in the trial.

Any resources provided to patients will be at the discretion of the clinician, and in accordance with evidence-based recommendations.

Follow-up on the trial will occur monthly via brief electronic data capture (SMS), with a longer follow-up at 3 and 6 months to gauge help-seeking behaviour.

Adherence: Participant monthly follow-ups will determine whether the assessment and diagnosis model translates to timely care.
Intervention code [1] 335372 0
Early detection / Screening
Intervention code [2] 335456 0
Treatment: Other
Description of the comparator or control
No control group.
Control group
Uncontrolled

Outcomes
Primary outcome [1] 346925 0
Feasibility of the combined assessment and diagnosis protocol (Weiner et al's (2017) Feasibility of Implementation Measure; FIM)
Timepoint [1] 346925 0
Immediately following the diagnostic appointment (T0).
Primary outcome [2] 346926 0
Acceptability of the combined assessment and diagnosis protocol (Weiner et al's (2017) Acceptability of Implementation Measure; AIM)
Timepoint [2] 346926 0
Immediately following the diagnostic appointment (T0).
Primary outcome [3] 347045 0
Appropriateness of the combined assessment and diagnosis protocol (Weiner et al's (2017) Intervention Appropriateness Measure; IAM)
Timepoint [3] 347045 0
Immediately following the diagnostic appointment (T0).
Secondary outcome [1] 468162 0
Near-miss safety events at work
Timepoint [1] 468162 0
Baseline (weeks -5 to -1) and post-treatment (3m)
Secondary outcome [2] 468163 0
Self-reported variability in daily productivity relative to typical
Timepoint [2] 468163 0
Baseline (weeks -5 to -1) and post-treatment (3m)
Secondary outcome [3] 468164 0
Frequency of risky driving habits
Timepoint [3] 468164 0
Baseline (weeks -5 to -1), and 3-months and 6-months post diagnosis
Secondary outcome [4] 468165 0
Confidence (how to manage sleep problems)
Timepoint [4] 468165 0
Baseline (weeks -5 to -1), and 3-months and 6-months post diagnosis
Secondary outcome [5] 468166 0
Sleep-Related Impairment
Timepoint [5] 468166 0
Baseline (weeks -5 to -1), and 3-months and 6-months post diagnosis
Secondary outcome [6] 468167 0
Sleep Disturbance
Timepoint [6] 468167 0
Baseline (weeks -5 to -1), and 3-months and 6-months post diagnosis
Secondary outcome [7] 468168 0
Time to help seeking (days)
Timepoint [7] 468168 0
Monthly, from post-diagnostic appointment (T0) to 6-month follow-up
Secondary outcome [8] 468169 0
Burnout
Timepoint [8] 468169 0
Baseline (weeks -5 to -1), and 3-months and 6-months post diagnosis
Secondary outcome [9] 468170 0
Turnover Intention
Timepoint [9] 468170 0
Baseline (weeks -5 to -1), and 3-months and 6-months post diagnosis
Secondary outcome [10] 468171 0
Productivity (presenteeism)
Timepoint [10] 468171 0
Baseline (weeks -5 to -1), and 3-months and 6-months post diagnosis
Secondary outcome [11] 468172 0
Help seeking for sleep (yes/no)
Timepoint [11] 468172 0
Monthly, from post-diagnostic appointment (T0) to 6-month follow-up
Secondary outcome [12] 468715 0
Self-efficacy for sleep management
Timepoint [12] 468715 0
Baseline (weeks -5 to -1), and 3-months and 6-months post diagnosis
Secondary outcome [13] 468716 0
Confidence (understanding sleep problems)
Timepoint [13] 468716 0
Baseline (weeks -5 to -1), and 3-months and 6-months post diagnosis

Eligibility
Key inclusion criteria
1. Aged 18-40 years
2. Employed in healthcare: (Nursing or midwifery; Medical practitioner (e.g. doctor, GP, surgeon, psychiatrist; Allied health (e.g. psychology, counselling, social work, physiotherapy, occupational therapy); Allied health science (e.g. pharmacy, radiography, sonography, optometry); Other health professional (e.g. paramedicine, dental, aged care)
3. Working >/= 15h/week
4. Currently residing in South Australia
5. Currently working shift work, or regularly work non-standard hours (for example, starting before 8:00am and/or finishing after 9:00pm)
6. Working shift work in current healthcare role between 6 months and 5 years
7. Perceived problems with sleep >/= 3 nights per week (initiating or maintaining sleep, unrefreshing sleep, dissatisfaction with sleep quality, snoring) and/or very worried about sleep
8. Meets criteria for one or more ICSD-3-TR or DSM-5-TR sleep disorders according to clinical interview and/or Level 2 Polysomnography.
9. Fluent in English and able to provide informed consent
Minimum age
18 Years
Maximum age
40 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
1. Ingested inhaled or injected any illicit drugs or cannabis in the past 4 weeks
2. Have drug dependencies that would mean they could not comply with the program
3. History of TBI, Stroke or neurodegenerative disorders (Parkinson's Dementia)
4. Pregnant, lactating, or caring for a newborn < 12 months
5. Have a sleep disorder which is being actively managed by another health practitioner
6. Have acute/unmanaged mental or physical health presentations which would preclude engagement with diagnosis and treatment (e.g. acute psychosis, suicidal ideation or intent)

Study design
Purpose of the study
Diagnosis
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
SA

Funding & Sponsors
Funding source category [1] 323049 0
Government body
Name [1] 323049 0
Australian Research Council
Country [1] 323049 0
Australia
Primary sponsor type
University
Name
Flinders University
Address
Country
Australia
Secondary sponsor category [1] 325991 0
None
Name [1] 325991 0
Address [1] 325991 0
Country [1] 325991 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 321451 0
Flinders University Human Research Ethics Committee
Ethics committee address [1] 321451 0
Ethics committee country [1] 321451 0
Australia
Date submitted for ethics approval [1] 321451 0
31/10/2025
Approval date [1] 321451 0
03/12/2025
Ethics approval number [1] 321451 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 153766 0
A/Prof Amy Reynolds
Address 153766 0
Flinders Health and Medical Research Building, Sports Road, Bedford Park SA 5042
Country 153766 0
Australia
Phone 153766 0
+61 8 8201 5196
Fax 153766 0
Email 153766 0
Contact person for public queries
Name 153767 0
Amy Reynolds
Address 153767 0
Flinders Health and Medical Research Building, Sports Road, Bedford Park SA 5042
Country 153767 0
Australia
Phone 153767 0
+61 8 8201 5196
Fax 153767 0
Email 153767 0
Contact person for scientific queries
Name 153768 0
Amy Reynolds
Address 153768 0
Flinders Health and Medical Research Building, Sports Road, Bedford Park SA 5042
Country 153768 0
Australia
Phone 153768 0
+61 8 8201 5196
Fax 153768 0
Email 153768 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.